Deel's Alex Bouaziz and Clarity's Michael Matias explain why a one-off identity check at hiring no longer holds as deepfake candidates reach real interviews.
Deel, the global people platform, has acquired Clarity, an AI cybersecurity company that specialises in identity verification, deepfake detection and fraud prevention.
Build an investment platform around investor trust and clear business goals—not appearances. Prioritize investor conversations, practical systems, and an aligned team.
If you’re thinking about launching an institutional investment platform, the legal side is only part of the story.
ISN's ISNetworld platform has standardised contractor compliance across four Honeywell Mexico sites, signalling broader industrial digitisation in Latin America.
ISN's ISNetworld platform has standardised contractor compliance across four Honeywell Mexico sites, signalling broader industrial digitisation in Latin America.
WeFi CEO Maksym Sakharov discusses what MiCA got right, the cost of compliance and why Europe cannot regulate stablecoin demand away.
MiCA, the EU’s Markets in Crypto-Assets Regulation, has given crypto firms a single European rulebook and, with it, a bill. As the framework takes full effect, the loudest voices in the debate have been stablecoin issuers and exchanges.
Stablecoins are growing fastest where they solve real problems—especially inflation, foreign exchange access, and slow payments—and Turkey shows why that utility could re
If you want to understand where stablecoin adoption is really headed, Turkey is one of the clearest places to look.
The 2 August milestone has passed. TTEC Digital's Amanda Panks on what has actually changed for banks, where the gaps are, and why the next test is the AI customers never
NetApp and Oracle have announced a fully managed, OCI-native storage service based on ONTAP, targeting AI and regulated enterprise workloads, due within 12 months.
intelliflo has bought Mabel Insights, folding its whole-of-market portfolio research tools into intelliflo office while keeping them free for advisers.
ANB033 significantly reduced intestinal damage and symptoms versus placebo in a Phase 1b gluten-challenge study, with a late-stage trial planned for 2027.
An independent Italian study found MicroPulse transscleral laser therapy reduced intraocular pressure by 37% over 24 months across early to advanced glaucoma.